The carbonyl reagent amino-oxyacetate is frequently used in metabolic studies to inhibit individual pyridoxal phosphate enzymes. The reaction of this compound with three such enzymes, aspartate transaminase, 4-aminobutyrate transaminase and dopa (3,4-dihydroxyphenylalanine) decarboxylase, was studied to determine the extent to which the inhibition is reversible and the rates at which it takes place. Reactions were followed by observing changes in the absorption spectra of the bound coenzyme and by measuring loss of enzyme activity. The reactions with aspartate transaminase and aminobutyrate transaminase were not rapidly reversible and had second-order rate constants (21°C) of 400 M-1 * s-' and 1300 M'1 * s-I respectively and at all concentrations studied showed the kinetics of a simple bimolecular reaction. The reaction with 4-aminobutyrate transaminase could not be reversed and that with aspartate transaminase could only be reversed significantly by addition of cysteinesulphinate to convert the enzyme into its pyridoxamine form. The first-order rate constant (21°C) for the reverse reaction was 4 x 10-5 s-I. Dopa decarboxylase inhibition by amino-oxyacetate was more rapid and more readily reversible, but measurements of rate and equilibrium constants were not obtained for this enzyme.
Amino-oxyacetate has been used frequently in metabolic studies with the intention of singling out one enzyme for inhibition. Much of this work has been aimed at inhibiting brain 4-aminobutyrate transaminase (EC 2.6.1.19) to increase concentrations of the neurotransmitter 4-aminobutyrate (e.g. Baxter & Roberts, 1961; Osuide, 1972) . The general reactivity of amino-oxyacetate towards pyridoxal phosphate-dependent enzymes is well recognized, since it is known that the compound reacts with 4-aminobutyrate transaminase (Wallach, 1961; Baxter & Roberts, 1961; Wu, 1976) , alanine transaminase (EC 2.6.1.2; Hopper & Segal, 1962) , glutamate decarboxylase (EC 4.1.1.15; Roberts & Simonsen, 1963) , alanine racemase (EC 5.1.1.1; Free et al., 1967) , histidine decarboxylase (EC 4.1.1.22; Leinweber, 1968) , D-amino acid transaminase (EC 2.6.1.6; Yonaha et al., 1975) and cystathionase (EC 4.4.1.1; Beeler & Churchich, 1976) . Aminooxyacetate is also widely used to block aspartate transaminase (EC 2.6.1.1) during metabolic studies where it is intended to be specific (Rognstad & Clark, 1974; Longshaw et al., 1972; Williamson et al., 1971 ).
Abbreviation used: Hepes, 4-(2-hydroxyethyl)-lpiperazine-ethanesulphonic acid. Vol. 171 Many studies in vitro have been made on the mechanism of amino-oxyacetate inhibition of various enzymes, e.g. alanine transaminase (Hopper & Segal, 1962) , pyridoxal kinase (EC 2.7.1.35; Davanzo et al., 1966) , glutamate decarboxylase (Roberts & Simonsen, 1963) and 4-aminobutyrate transaminase (Wu, 1976) . In these studies the inhibition is treated as though it were of the rapidly reversible type, classically divided into competitive, non-competitive, uncompetitive etc. In these experiments amino-oxyacetate was included with substrates, enzyme and very often pyridoxal phosphate, with which it reacts, for periods of 5-60 min and then the amount of product was used in the construction of reciprocal plots as though it represented initial velocity. In one case the apparent inhibition of pyridoxal kinase (Davanzo et al., 1966) is clearly due to a stoicheiometric reaction with the substrate. Other workers (e.g. Karpeisky et al., 1963) have attempted quantification of the efficacy of this and other carbonyl reagents by finding the concentration at which half the enzyme activity remains after various times (150).
The present work is intended to investigate the inhibition by amino-oxyacetate of three pyridoxal phosphate enzymes to examine the basis for claims to specificity and to find the extent to which the inhibition might be considered rapidly reversible. 
Enzymes
Aspartate transaminase was purified from pig heart by the modification described by MartinezCarrion et al. (1967) of the method of Jenkins et al. (1959) . 4-Aminobutyrate transaminase was prepared from rabbit brain as described by John & Fowler (1976) .
Pig kidney dopa decarboxylase was prepared by homogenizing the cortex of ten kidneys in 2 vol. of 0.14M-NaClwith a Waring blender. After centrifuging (3.2 x 106g-min), the supernatant was treated with pyridoxal phosphate (final concn. 0.1mm) and 140g of (NH4)2SO4 added per litre of supernatant. After centrifuging (150000g-min), the precipitate was discarded and to each litre of clear supernatant was added 330g of (NH4)2SO4. The precipitate obtained after centrifuging (150000g-min) was dissolved in 10mM-sodium phosphate buffer, pH7.2, containing 10#uM-pyridoxal phosphate and subjected to the column fractionations described below. Between each fractionation, active fractions were precipitated by adding 450mg of (NH4)2SO4/ml.
(1) DEAE-cellulose. A column (4.3cm x 30cm) was equilibrated with 10mM-sodium phosphate buffer containing IOp,M-pyridoxal phosphate, 0.1 mM-EDTA and 1 mM-2-mercaptoethanol, pH 7.2, and developed with a linear gradient from equilibration buffer to 0.2M-NaCl in the same buffer; total volume used was 1 litre.
(2) QAE-Sephadex. A column (4.3cm x 15cm) was equilibrated with 80mM-sodium phosphate buffer containing the same additions as for fractionation (I) and developed with a linear gradient from equilibration buffer to 0.2M-NaCl in the same buffer; total volume used was 2 litres. (3) DEAE-cellulose. A column (1.6cm x 15cm) was equilibrated with 5mM-sodium phosphate containing 0.1 mM-dithiothreitol, pH 6.5, and developed with a linear gradient from starting buffer to 0.5M-NaCl in the same buffer.
(4) QAE-Sephadex. A column (1.6cm x 8cm) was equilibrated with 5mM-sodium pyrophosphate buffer containing 1 mM-2-mercaptoethanol, 0.1 mm-EDTA and 70mM-NaCl, pH 8.5, and developed with a linear gradient from starting buffer to the same buffer containing 0.4M-NaCl; total volume used was 500ml.
(5) Sephadex G-100. A column (2.2cm x 85cm) was equilibrated with 10mM-sodium phosphate containing 0.1 mM-dithioethreitol, pH 6.8.
The procedure is a modification of one given by Professor Carlo Turano (personal communication).
Enzyme assays
Aspartate transaminase was measured by the method of Karmen (1955) by using conditions described by John & Fasella (1969) . 4-Aminobutyrate transaminase was measured by the method of Salvador & Albers (1959) and dopa decarboxylase as described by Charteris & John (1975) .
Spectrophotometry
U.v. and visible absorption spectra were determined by using either a Unicam SP. 800 or a Beckman model 25 recording spectrophotometer, and the latter was also used to follow the course of the slower reactions. Faster reactions were followed with a Durrum-Gibson stopped-flow spectrophotometer.
Results and Discussion
Spectral changes resultingfrom combination ofaminooxyacetate with aspartate transaminase
The combination of amino-oxyacetate with aspartate transaminase is accompanied by a change in the absorption spectrum of enzyme-bound pyridoxal phosphate. The peak at 360nm attributed to the aldimine formed between the coenzyme and a lysine residue (Braunstein, 1964; Guirard & Snell, 1964) shifts to 385nm, as shown in Fig. I(a) . This may be attributed to substitution by the amino group of amino-oxyacetate to form an oxime. At the concentrations used in this experiment the reaction is relatively slow but apparently irreversible, so that the compound can be used as an effective titrating agent, as shown in Fig. l Aspartate transaminase (l.1 ml, 85,UM) was treated with successive portions (5pu1) of 6.2mM-amino-
oxyacetate. An absorption spectrum was recorded when reaction was complete after each addition. The original spectrum, that showing lowest absorption at 400nm, and those observed after each of three additions axe shown in (a). Total changes in A400 for an experiment that was identical except that 5mM-amino-oxyacetate was used are also shown in (b). In this case several more portions ofamino-oxyacetate were added after reaction was complete. The reactions were carried out at 21.6 'C in 0.04 M-Hepes adjusted to pH8.0 with NaOH. Course of the reaction between aspartate transaminase and amino-oxyacetate Data obtained from each of the separate reactions used to give the spectra shown in Fig. 1 were plotted to give the second-order rate constant as shown in Fig. 2 . Under these conditions, therefore, the simplest interpretation is that the reaction is an irreversible bimolecular process with a rate constant of 4.2 x 102 M-l s-l at 21.6°C.
At higher concentrations of amino-oxyacetate, because the reaction becomes too fast for conventional mixing methods, the stopped-flow method for rapid mixing was used. Fig. 3 shows the course of the reaction when amino-oxyacetate concentration was 20mm and the enzyme concentration was 0.06mM. A semilogarithmic plot showed the reaction to be first order for at least 95 % of its course, and this was also true for the reactions at other inhibitor concentrations, the pseudo-first-order constants for which Vol. 171 are plotted against amino-oxyacetate concentration in Fig. 4 . The second-order rate constant determined from the slope of this line is 3.9 x 102M-I-s1 (21°C), in good agreement with that obtained in the earlier experiments.
The point under examination here is whether initial binding, such as might be expected from ionic interaction between the'carboxy group of the aminooxyacetate and a positive centre on the enzyme normally used to bind substrate, is sufficiently strong that significant concentrations of a reversible complex are formed as in eqn. (1) So long as the cysteinesulphinate reaction is relatively fast, the rate of EM formation, which can be followed by observing the peak at 330nm, will be a measure of the rate of dissociation of amino-oxyacetate from EL.
In a separate experiment with the same concentrations of native enzyme (85AuM) and cysteinesulphinate (2.2mM) the spectral change was found to be complete within the mixing time of 10s, showing that the conversion of EL into EM by cysteinesulphinate is very fast relative to the rate of the spectral changes shown in Fig. 5 . The further observation that the rate of the slow reaction is unaffected by cysteinesulphinate concentration supports the proposed mechanism.
1.! A A (nm) Fig. 5 . Spectral changes occurring when cysteinesulphinate reacts with the aspartate transaminase-amino-oxyacetate complex The sample of enzyme-amino-oxyacetate complex (1.1 ml, 85AM) formed in the experiment of Fig. 1(a) , in which stoicheiometric amounts of the two reactants had been mixed and left for several hours, was treated with 5,ul of 0.5M-cysteinesulphinate and the absorption spectrum recorded at intervals. The spectrum with the highest absorbance at 385nm was recorded 16min after addition of cysteinesulphinate and the remainder were obtained at the times indicated in (1)
AMINO-OXYACETATE INHIBITION OF PYRIDOXAL ENZYMES
We conclude therefore that the rate of increase in A330 and the rate of recovery of enzyme activity, which run together as shown in Fig. 6 , are a measure of the slow rate of dissociation of amino-oxyacetate from the aldimine form of the enzyme. The continuous line through the point of Fig. 6 is theoretical, constructed for a first-order process occurring with a rate constant of 4.0 x 105s' with AA385 = 0.55 and specific activity of 130 units/mg (where a unit of activity is defined as the amount ofenzyme required to convert lpmol of substrate/min) as the respective end-points. By using this value for the rate constant for dissociation and the value of 4.2 x 102M-1-S-1 for the association rate constant given above a dissociation equilibrium constant of 95nm can be calculated.
Spectral changes resultingfrom combination ofaminooxyacetate with 4-aminobutyrate transaminase
The combination of amino-oxyacetate with 4-aminobutyrate transaminase gives a less marked spectral shift than with aspartate transaminase (Fig. 7a ) and the reaction is thus more readily examined by difference spectroscopy (Fig. 7b) . Fig. 8(a) shows the results of a titration of 4-aminobutyrate transaminase with amino-oxyacetate by using difference spectroscopy to follow the changes occurring. After each addition the reaction was observed until it had stopped before the measure- (Fig. 5) Fig. 8 shows that equal amounts of enzyme activity are lost with each successive addition and that this linear dependence continues until activity loss is complete. This observation and the linear spectral titrations show that at these concentrations the reaction is essentially irreversible. Calculations from the data of Fig. 8 give the concentration of enzyme that reacts with amino-oxyacetate as 12.5pm, whereas calculations using protein concentration and mole,ular weight (116000; John & Fowler, 1976) give an enzyme concentration of 32,uM.
The non-reactivity of a certain amount of the enzyme towards amino-oxyacetate has been observed with other preparations of the enzyme, and on occasion the proportion of reactive enzyme has been very close to 50 %. It is possible that the enzyme has 'half-of-the-sites reactivity' (Levitzki et al., 1971 ), but it seems more probable that loss of activity is progressive and the occasional approximation to 50% is coincidental.
Course of the reaction between amino-oxyacetate and 4-aminobutyrate transaminase The results of the time-dependent inhibition of 4-aminobutyrate transaminase by amino-oxyacetate at 25°C, 37°C and in the presence of IOmM-L-4-aminobutyrate are shown in Fig. 9 . The secondorder constants are 1.3 x 103M-1-s-(25°C), 2.7 x 103M-1-S-1 (370C) and 3.5 x 102M-1 s-1 (37°C with 10mM-4-aminobutyrate).
Extensive dialysis did not restore the activity of the inhibited enzyme even if pyridoxal phosphate (0.1 mM) was included in the dialysis buffer. It is possible that the inhibition may be reversible, but dissociation must be very slow. In this case, unlike with aspartate transaminase, a compound like cysteinesulphinate is not available, so that the reversibility of the reaction cannot so readily be examined. The enzyme (0.4ml; 1.5mg/ml in 0.1 M-sodium acetate, pH5.5) was treated with 2p1 of 8 mM-aminooxyacetate (a).
The spectrum with the highest peak at 405 nm is that of the native enzyme and the other is that recorded a few minutes after addition of the amino-oxyacetate. No further change occurred with time or with further addition of amino-oxyacetate. The difference spectra (b) were obtained by adding two successive portions (2pl) of 0.8mM-amino-oxyacetate to 0.4ml of enzyme (1.5 mg/ml in 0.1 M-sodium acetate buffer, pH 5.5.). The A428 was observed until constant and the change [Amino-oxyacetatel (pM) in A428 used to construct the titration curve (-). In other experiments (enzyme concentration 1.9 mg/ml) Fig. 8 . Titration of 4-aminobutyrate transaminase with the extent of reaction was monitored by measuring amino-oxyacetate loss of activity. The points show activity remaining Theenzyme (0.4ml; 1.5mg/ml)was titrated by adding after 90min (U) and 5h (A) treatment with aminosuccessive portions (2,pl) of0.8 mM-amino-oxyacetate. more complicated than those for the other two enzymes. Fig. 10 shows the spectrum of the native enzyme and the spectra obtained after several additions of amino-oxyacetate. The first addition (24#M) produced a decrease at 420nm, but further additions produced no further decrease at this wavelength. An estimate of the enzyme molarity was made by determining the amount of pyridoxal phosphate released by 0.1 M-NaOH and using the known absorption coefficient of the free coenzyme under these conditions (Peterson & Sober, 1954) , and the value determined was 26pM. The reaction between the 420nm-absorbing form of the enzyme and amino-oxyacetate appeared to go to completion as measured at this wavelength. Although no value for the rate constant can be given, because the reaction was complete within the time needed to record the spectrum, it is clearly much higher than those for the other two enzymes. By assuming that the reaction was at least 90% complete within lOs a lower limit for the rate constant was estimated to be 2.5 x Vol. 171 The enzyme (0.9 ml; 33,uB in 0.05 B-Tris/HCI, pH7.5) was treated with 5,pl of 4.3 mM-amino-oxyacetate and the spectrum recorded after 5min: 10min after addition of a further 5,p1 of the same amino-oxyacetate, another spectrum was recorded. Spectra were also drawn 30min after each of the subsequent IOpl additions; the second of these was of 23mM-aminooxyacetate. After each spectrum had been drawn two Spl samples were removed for assay of enzymic activity. The spectrum of native enzyme is that with the peak above 400nm and the spectra with increasing absorptions at 390nm are those obtained after addition of successive portions of amino-oxyacetate solution. The lowest line is the baseline obtained by using the buffer solution alone.
10-IM--s-1. However, although further addition of amino-oxyacetate produced no further decrease at 420nm, the increase at 385nm observed with the first addition continued for two more additions of amino-oxyacetate to a total concentration of 72pM. It is possible that this is caused by reaction with coenzyme bound in a different way but also forming the oxime.
Removal of a sample of the enzyme after the first addition of amino-oxyacetate gave an activity 777 il measurement, from a 5min incubation, which was 20% of that of the untreated enzyme. The value obtained after the second addition of amino-oxyacetate was still 10% that of the untreated enzyme. The most reasonable explanation of this is that the 50-fold dilution of the sample that occurs in adding it to the assay solution lowers the concentration sufficiently to allow a certain amount of reversal. If the dissociation is rapid, these data would be accounted for by a dissociation constant of 0.2AM, ignoring any effect of the substrate. The reaction between dopa decarboxylase and amino-oxyacetate, although not as well characterized as those for the other two enzymes, is clearly much faster and more readily reversible.
For two of the enzymes studied in this work, inhibition may be considered complete so long as an amount of amino-oxyacetate is used that is at least stoicheiometric with the enzyme. This is also true for cystathionase (Beeler & Churchich, 1976 ), which appears to be the only other enzyme that has been investigated from this point of view. It seems reasonable to suppose that oxime formation between amino-oxyacetate and many other pyridoxal phosphate-dependent enzymes is similarly complete and that its use as a selective inhibitor is unwise. However, the three enzymes for which data are available show differences of rates of reaction, which, although not great, would confer some kinetic specificity.
The molecular basis for the observed differences in rate constant is difficult to ascertain. The rate constant for the reaction of amino-oxyacetate with pyridoxal phosphate is 4.8m-s-1 (25°C) (Beeler & Churchich, 1976) . The reaction with the internal aldimine that, because of the absorption spectra and by analogy with other pyridoxal phosphatedependent enzymes, may be presumed to exist between the coenzyme and a lysine residue of these enzymes, would be expected to be much faster than that with the free aldehyde simply because of the greater reactivity of aldimines compared with the free aldehydes (Jencks & Cordes, 1963) . Jencks & Cordes (1963) also showed that protonated aldimine reacts faster than the unprotonated form, but it is not possible to tell from their data what the second-order constants for the transaldimination reactions are, because in their experiment only catalytic steady-state concentrations of aldimine were present. It is clear, however, that the rate constant of 61 m-* s' for cystathionine and amino-oxyacetate (Beeler & Churchich, 1976) can easily be reached without any directive effects caused by interaction between the carboxy group of the inhibitor and the enzyme, since this value comes within the range of values reported by Jencks & Cordes (1963) . The values for aspartate transaminase (420M-1 s-' at 22°C) and 4-aminobutyrate transaminase, (1300m-1 s-i at 25°C), are higher than anything found by Jencks & Cordes (1963) , but this is probably because the proportion of aldimine present in their system was very low at the concentrations of pyridoxal phosphate and base that they used. The view that the carboxy group of amino-oxyacetate has little directive effect in these reactions is borne out by the observation that the compound reacts only twice as fast as hydroxylamine with 4-aminobutyrate transaminase.
The measurement of apparent dissociation constants (Wallach,' 1961; Wu, 1976) for amino-oxyacetate and 4-aminobutyrate transaminase by classical steady-state methods is clearly not feasible for this slowly reacting irreversible inhibitor. At concentrations in the region of lpM used in these earlier studies the half-time for inactivation in the absence of substrate would be about 5min, so that inactivation would be occurring during the incubation. Increasing substrate concentrations increase the product concentration not only by saturating the enzyme more but also by slowing inactivation. When, by chance, incubation times and inactivation times are roughly equal and the resulting product concentrations are mistakenly plotted as initial velocities, the patterns obtained resemble those for classical competitive inhibition. Dissociation constants derived from such treatment are obviously spurious.
